FDA official logo
GSRS logo
PFDA official logo

PANITUMUMAB

  • UNII: 6A901E312A
  • Preferred Substance Name: PANITUMUMAB

  • 339177-26-3
  • ABENIX
  • ABX-EGF
  • E7.6.3
  • IMMUNOGLOBULIN, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL ABX-EGF HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ABX-EGF LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN, HUMAN (ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) MONOCLONAL ANTIBODY (ABX-EGF)
  • PANITUMUMAB [EMA EPAR]
  • PANITUMUMAB [INN]
  • PANITUMUMAB [JAN]
  • PANITUMUMAB [MART.]
  • PANITUMUMAB [MI]
  • PANITUMUMAB [PURPLE BOOK, CDER]
  • PANITUMUMAB [USAN]
  • PANITUMUMAB [VANDF]
  • PANITUMUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.